Navigation Links
WHO Introduces the Helminth Drug Initiative With Special Supplement in the Expert Opinion on Drug Discovery
Date:10/18/2007

LONDON, October 18 /PRNewswire/ -- Helminth infections are responsible for a huge health burden on developing country populations, and the number of drugs available to treat them is incredibly limited.

The paucity of products in development for helminth diseases has necessitated a focused initiative to boost the R&D pipeline for these diseases. Consultation meetings organised by the WHO Research and Training in Tropical Diseases (TDR) Programme in collaboration with the Japanese Society of Parasitology led to the establishment of the Helminth Drug Initiative (HDI), which aims to facilitate R&D against human parasitic worm infections.

In a freely available 103-page peer-reviewed special issue of Expert Opinion on Drug Discovery, the rationale behind the HDI is documented, as well as reports of technical consultations and recommendations that led to the initial establishment of the Initiative within TDR.

"The Helminth Drug Initiative is an integral part of an innovative drug discovery platform established by TDR based on a coordinated network of partners from industry and academia from the developed and developing countries ", commented Dr Solomon Nwaka, who leads drug discovery efforts and the HDI.

The special issue focusing on the Helminth Drug Initiative of the Expert Opinion on Drug Discovery is available for free download at: http://www.pjbpubs.com/uploads/content/expertopin/eodc_freedownload.htm.

About Expert Opinion

The Expert Opinion series provides systematic and authoritative reviews to support every stage of the drug discovery and R&D pipeline from target to market. Each of the eleven journals in the series covers a specific aspect of the pharmaceutical pipeline.

The series contains the following journals: Expert Opinion on Biological Therapy, Expert Opinion on Drug Delivery, Expert Opinion on Drug Discovery, Expert Opinion on Drug Metabolism & Toxicology, Expert Opinion on Drug Safety, Expert Opinion on Emerging Drugs, Expert Opinion on Investigational Drugs, Expert Opinion on Medical Diagnostics, Expert Opinion on Pharmacotherapy, Expert Opinion on Therapeutic Patents, and Expert Opinion on Therapeutic Targets.

For further information:

Phil Garner, Publisher

Telephone: +44-(0)20-7017-6775

Email: phil.garner@informa.com

Website: http://www.expertopin.com


'/>"/>
SOURCE Expert Opinion
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. GE Healthcare introduces MR imaging product
2. Online fishing site introduces interactive maps
3. GE introduces remotely hosted health services
4. Norlight introduces new e-mail security service
5. Angel network introduces ePlan
6. RedPrairie Corp. introduces new supply chain software
7. GE introduces compact ultrasound system for women
8. MailFoundry introduces new e-mail archive product
9. Madison biotech introduces drug discovery advance
10. Alfalight introduces new 25-watt pump module
11. Wisconsin introduces new state IT plan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... YORK , June 23, 2016 ... trading session at 4,833.32, down 0.22%; the Dow Jones Industrial ... S&P 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has initiated ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ), ... Therapeutics Inc. (NASDAQ: BIND ). Learn more about ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity Products, a division ... tuned and optimized exclusively for Okuma CNC machining centers at The International Manufacturing ... collaboration among several companies with expertise in toolholding, cutting tools, machining dynamics and ...
(Date:6/22/2016)... 2016 Cell Applications, Inc. and StemoniX ... produce up to one billion human induced pluripotent ... week. These high-quality, consistent stem cells enable researchers ... spend more time doing meaningful, relevant research. This ... manufacturing process that produces affordable, reliable HiPSC for ...
Breaking Biology Technology:
(Date:6/3/2016)... LONDON , June 3, 2016 /PRNewswire/ ... Transport Management) von Nepal ... ,Angebot und Lieferung hochsicherer geprägter Kennzeichen, einschließlich ... weltweit führend in der Produktion und Implementierung ... an der Ausschreibung im Januar teilgenommen, aber ...
(Date:6/2/2016)... June 2, 2016   The Weather Company , an ... Ads, an industry-first capability in which consumers will be able ... to ask questions via voice or text and receive relevant ... Marketers have long sought an advertising solution ... can be personal, relevant and valuable; and can scale across ...
(Date:6/1/2016)... 1, 2016 Favorable Government Initiatives ... and Criminal Identification to Boost Global Biometrics System Market ... TechSci Research report, " Global Biometrics Market By ... and Opportunities, 2011 - 2021", the global biometrics market ... on account of growing security concerns across various end ...
Breaking Biology News(10 mins):